# STOCKHOLM 1.0
#=GF ID   CCM2_C
#=GF AC   PF16545.9
#=GF DE   Cerebral cavernous malformation protein, harmonin-homology 
#=GF AU   Coggill P;0000-0001-5731-1588
#=GF SE   pdb_4fqn
#=GF GA   27.30 27.30;
#=GF TC   27.30 27.70;
#=GF NC   27.20 27.00;
#=GF BM   hmmbuild HMM.ann SEED.ann
#=GF SM   hmmsearch -Z 75585367 --cpu 4 -E 1000 HMM pfamseq
#=GF TP   Domain
#=GF RN   [1]
#=GF RM   14624391
#=GF RT   Mutations in a gene encoding a novel protein containing a
#=GF RT   phosphotyrosine-binding domain cause type 2 cerebral cavernous
#=GF RT   malformations.
#=GF RA   Liquori CL, Berg MJ, Siegel AM, Huang E, Zawistowski JS, Stoffer
#=GF RA   T, Verlaan D, Balogun F, Hughes L, Leedom TP, Plummer NW,
#=GF RA   Cannella M, Maglione V, Squitieri F, Johnson EW, Rouleau GA,
#=GF RA   Ptacek L, Marchuk DA;
#=GF RL   Am J Hum Genet. 2003;73:1459-1464.
#=GF RN   [2]
#=GF RM   23266514
#=GF RT   Structural studies of cerebral cavernous malformations 2 (CCM2)
#=GF RT   reveal a folded helical domain at its C-terminus.
#=GF RA   Fisher OS, Zhang R, Li X, Murphy JW, Demeler B, Boggon TJ;
#=GF RL   FEBS Lett. 2013;587:272-277.
#=GF DR   INTERPRO; IPR032375;
#=GF DR   SO; 0000417; polypeptide_domain;
#=GF CC   CCM2_HHD is a folded-helical region of a family of vertebral
#=GF CC   proteins, mutations in which cause cerebral cavernous
#=GF CC   malformations (CCMs). These malformations are congenital
#=GF CC   vascular anomalies of the central nervous system that can result
#=GF CC   in haemorrhagic stroke, seizures, recurrent headaches, and focal
#=GF CC   neurologic deficits [1]. This domain is structurally homologous
#=GF CC   to the N-terminal domain of harmonin, so it is named the CCM2
#=GF CC   harmonin-homology domain or CCM2_HHD [2]. This protein is often
#=GF CC   called Malcavernin.
#=GF SQ   6
#=GS C9JUH3_HUMAN/190-290  AC C9JUH3.1
#=GS H3A0W6_LATCH/433-532  AC H3A0W6.1
#=GS H0Z869_TAEGU/1-84     AC H0Z869.2
#=GS G3HE99_CRIGR/163-262  AC G3HE99.1
#=GS M4A4G7_XIPMA/449-548  AC M4A4G7.2
#=GS W5MDU1_LEPOC/452-551  AC W5MDU1.1
C9JUH3_HUMAN/190-290             SESELSASATELLQDYMLTLRTKLSSQEIQQFAALLHEYRNGASIHEFCINLRQLYGDSRKFLLLGLRPFIPEKDSQHFENFLETIGVKDGRGIITDSFGR
H3A0W6_LATCH/433-532             SGSDHGNAVVEMLQEYMVTLRNKLSPLEIQEFALLLRKYRMGSSVEKYCSELLHLYGEKRKFLLLGMRPFIPDTDIGYFEQFLENIGIREG.GILTDSFGR
H0Z869_TAEGU/1-84                ................MVTLRNKLSPQEIQQFAILLREYRLGTPVQEYCTELLHLYGDRRKFLLLGMRPFIPDQDIGYFETFLESIGIREG.GILTDSFGR
G3HE99_CRIGR/163-262             SSIDHSSWAFEQLQDYMVTLRSKLGPPEIQQFAMLLRDYRLGLPIQDYCAGLQKLYGDRRKFLLIGMRPFIPDQDIGYFESFLESVGIREG.GILTDSFGR
M4A4G7_XIPMA/449-548             SDGADSNPALLLMQEYMITLRNKLNPLELQQFAVLLREYRLGSNIDHFCSELLQLYGDKRKFLLLGMRPFIPDKDVGVFEEFLESIGIREG.GILTDSFGR
W5MDU1_LEPOC/452-551             SESEQSSVEVQLLQEYMITLRSKLSPPEIQQFALLLREYRMGAHIEEFCSDLLQLYGDKRKFLLLGMRPFIPDKDVGVFESFLESIGIREG.GILTDSFGR
#=GC seq_cons                    Spu-pSssshphLQ-YMlTLRsKLSP.EIQQFAlLLREYRhGusIc-aCo-LLpLYGD+RKFLLLGMRPFIPDpDlGaFEsFLESIGIREG.GILTDSFGR
